1. |
T. Zheng, T. R. Holford, Y. Chen, et al., Time Trend and Age-Period-Cohort
Effect on Incidence of Thyroid Cancer in Connecticut, 1935-1992, International
Journal of Cancer 67 (1996): 504-9. |
2. |
B. L. Solomon, L. Wartofsky, and K. D. Burman,
Current Trends in the Management of Well-Differentiated Papillary
Thyroid Carcinoma, Journal of Clinical Endocrinology and Metabolism
81 (1996): 333-39. |
3. |
R. L. Rossi, B. Cady, and M. L. Silverman, Surgically Incurable
Well-Differentiated Thyroid Carcinoma: Prognostic Factors and Results
of Therapy, Archives of Surgery 123 (1988): 569-74. |
4. |
D. Zimmerman, I. D. Hay, and I. R. Gough, Papillary
Thyroid Carcinoma in Children and Adults: Long-Term Follow-up of I039
Patients Conservatively Treated at One Institution during Three Decades,
Surgery 104 (1988): 1157-66. |
5. |
A. Schindler, G. Van Melle, B. Evequoz, et al., Prognostic Factors
in Papillary Carcinoma of the Thyroid, Cancer 68 (1991): 324-30. |
6. |
D. P. Aiello and A. Manni, Thyroglobulin Measurements
vs. Iodine 131-I Total-Body Scan for Follow-up of Well-Differehtiated
Thyroid Cancer, Archives of Internal Medicine 150 (1990): 437-39. |
7. |
A. Brander, P. Viikinkoski, J. Nickels, et al., Thyroid Gland: U.S.
Screening in a Random Adult Population, Radiology 181 (1991): 683-87. |
8. |
F. S. Greenspan, The Role of Fine-Needle Aspiration
Biopsy in the Management of Palpable Thyroid Nodules, Pathology Patterns
108, no. 4, suppl. (1997): S26-S30. |
9. |
M. Boignon and D. Moyer, Solitary Thyroid Nodules: Separating Benign
from Malignant Conditions, Postgraduate Medicine 98, no. 2 (1995):
73-80. |
10. |
R. M. Tuttle, H. Lemar, and H. B. Burch, Clinical
Features Associated with an Increased Risk of Thyroid Malignancy in
Patients with Follicular Neoplasia by FineNeedle Aspiration, Thyroid
8, no. 5 (1998): 377-83. |
11. |
E. Papini, L. Petrucci, R. Guglielmi, et al., Long-Term Changes
in Nodular Goiter: A 5-Year Prospective Randomized Trial of Levothyroxine
Suppressive Therapy for Benign Cold Thyroid Nodules, Journal of Clinical
Endocrinology and Metabolism 83 (1998): 780-83. |
12. |
A. E. Schwartz, O. H. Clark, P. Ituarte, et al.,
Therapeutic Controversy: Thyroid Surgery-The Choice, Journal of Clinical
Endocrinology and Metabolism 83 , no. 4 (1998): 1097-1105. |
13. |
L. A. Burmeister, R. P. du Cret, and C. N. Mariash, Local Reactions
to Radioiodine in the Treatment of Thyroid Cancer, American Journal
of Medicine 90 (1991): 217-22. |
14. |
P. W. Ladenson, L. E. Braverman, E. L. Mazzaferri,
et al., Comparison of Administration of Recombinant Human Thyrotropin
with Withdrawal of Thyroid Hormone for Radioactive lodine Scanning
in Patients with Thyroid Carcinoma, New England Journal of Medicine
337, no. 13 (1997): 888-96. |
15. |
J. D. Pineda, T. Lee, K. Ain, et al., lodine-131 Therapy for Thyroid
Cancer Patients with Elevated Thyroglobulin and Negative Diagnostic
Scan, Journ:al of Clinical Endocrinology and Metabolism 80 (1995):
1488-92. |
16. |
P. Hall, L. E. Holm, G. Lundell, et al., Cancer
Risks in Thyroid Cancer Patients, British Journal of Cancer 64 (1991):
159-63. |
|